The Australian Government is supporting Australia’s capacity to develop industry-independent cancer clinical trial protocols. The following Multi-site Collaborative Cancer Clinical Trials Groups are currently funded by Cancer Australia:
- Australasian Gastro-Intestinal Trials Group
- Australasian Leukaemia and Lymphoma Group
- Australia and New Zealand Sarcoma Association
- Australian and New Zealand Children’s Haematology and Oncology Group
- Australian and New Zealand Urogenital and Prostate Cancer Trials Group
- Australia New Zealand Gynaecological Oncology Group
- Breast Cancer Trials
- Cancer Symptom Trials
- Cooperative Trials Group for Neuro-Oncology
- Melanoma and Skin Cancer Trials
- Primary Care Collaborative Cancer Clinical Trials Group
- Psycho-Oncology Co-operative Research Group
- Thoracic Oncology Group Australasia
- Trans-Tasman Radiation Oncology Group
The primary aim of the funding is to support the Groups to develop industry-independent cancer clinical trial protocols. The broader program objectives are to:
- Increase the number of cancer clinical trials conducted in Australia
- Increase participation in clinical trials by people affected by cancer
- Increase the number of clinical sites actively participating in cancer clinical trials
- Increase the involvement of policy makers, clinicians, researchers and consumers in the development of cancer clinical trials
- Increase Australia’s Multi-site Collaborative Clinical Trials Group participation in national multi-group or international cancer clinical trials in Australia